Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulceransKatharina Röltgen, Gerd PluschkeMethods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Overview: Mycobacterium ulcerans Disease (Buruli Ulcer)Katharina Röltgen, Gerd PluschkeMethods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Overview: Development of Drugs Against Mycobacterium ulceransGerd Pluschke, Katharina RöltgenFrontiers in Microbiology|June 12, 2020
Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulceransKatharina Röltgen, Gerd PluschkeAnnual Review of Pathology|September 22, 2023
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the BeginningKatharina Röltgen, Scott D BoydCell Host & Microbe|June 27, 2021
Antibody and B cell responses to SARS-CoV-2 infection and vaccinationKatharina Röltgen, Scott D BoydInfection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 7, 2012
The genome, evolution and diversity of Mycobacterium ulceransKatharina Röltgen, Timothy P Stinear, Gerd PluschkeAntimicrobial Agents and Chemotherapy|September 26, 2012
Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulceransNicole Scherr, Katharina Röltgen, Matthias Witschel, et al.Plos Neglected Tropical Diseases|February 25, 2021
The cell surface protein MUL_3720 confers binding of the skin pathogen Mycobacterium ulcerans to sulfated glycans and keratinChristopher J Day, Katharina Röltgen, Gerd Pluschke, et al.Emerging Infectious Diseases|November 18, 2017
Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer-Endemic Area, Northern Queensland, AustraliaKatharina Röltgen, Gerd Pluschke, Paul D R Johnson, et al.Pageof 7